Tracking down metabolic vulnerabilities in CDK12-mutant prostate cancer

Clin Transl Discov. 2024 Aug;4(4):e345. doi: 10.1002/ctd2.345. Epub 2024 Jul 19.

Authors

Wei-Ling Tu^{1

2

3}, Mu-En Wang^{1

2

3}, Ming Chen^{1

2}

Affiliations

¹ Department of Pathology, Duke University School of Medicine, Durham, North Carolina, USA.
² Duke Cancer Institute, Duke University, Durham, North Carolina, USA.
³ These authors contributed equally.

PMID: 39183936
PMCID: PMC11340202 (available on 2025-08-01)
DOI: 10.1002/ctd2.345

No abstract available

Publication types

Comment

Grants and funding